Search Results - Sahmanovic Hrgovcic, Azra

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Monitoring of erlotinib in pancreatic cancer patients during long-time administration and comparison to a physiologically based pharmacokinetic model

    Monitoring of erlotinib in pancreatic cancer patients during long-time administration and comparison to a physiologically based pharmacokinetic model by Gruber, Andrea, Czejka, Martin, Buchner, Philipp, Kitzmueller, Marie, Kirchbaumer Baroian, Nairi, Dittrich, Christian, Sahmanovic Hrgovcic, Azra

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial

    Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial by Dittrich, Christian, Königsberg, Robert, Mittlböck, Martina, Geissler, Klaus, Sahmanovic-Hrgovcic, Azra, Pleiner-Duxneuner, Johannes, Czejka, Martin, Buchner, Philipp

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: